Vera Bradley, Inc. (NASDAQ:VRA) price target was reduced by Baird after missing Q2 results. The firm reiterated its Outperform rating due to the company’s substantial growth prospects, broad portfolio, and easier second half comparisons.
Don’t Miss: What ELSE Does Apple Have Planned for September?
QUALCOMM Incorporated (NASDAQ:QCOM): Following a meeting with Qualcomm’s senior management, Oppenheimer is optimistic regarding the outlook for the company’s QCT unit. The firm predicts that the unit’s margins will show improvement, and it keeps an Outperform rating on the stock.
Intel Corporation (NASDAQ:INTC): According to Baird, Intel continues to have a chance to meet the low end of its Q3 guidance due to a PC rebound in September and revenue momentum in Asia. The firm also views its valuation as remaining attractive and keeps its Outperform rating and $33 price target.
ArQule Inc. (NASDAQ:ARQL): Leerink sees low risk that ArQule’s western Phase III MARQUEE trial of tivantinib will be noticeably affected by signals of interstitial lung disease seen in the Asian trial ATTENTION. The firm views shares of ArQule as attractively valued heading into data readouts over the next 12 months and keeps an Outperform rating on the stock.
Dycom Industries Inc. (NYSE:DY) price target has been decreased by Imperial Capital after the company showed weaker than expected Q4 results, but the firm keeps an Outperform rating on the stock.
Don’t Miss: Time Warner Gears Up to Face Google.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.